Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Large, Randomised, Parallel-group, Controlled Trial, With Patients Randomly Allocated to Either N2O-containing (70% N2O in Oxygen [FiO2 0.3]) or N2O-free (70% Nitrogen in Oxygen [FiO2 0.3]).

NCT00430989 is registered in ClinicalTrials.gov with Bayside Health as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00430989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Large, Randomised, Parallel-group, Controlled Trial, With Patients Randomly Allocated to Either N2O-containing (70% N2O in Oxygen [FiO2 0.3]) or N2O-free (70% Nitrogen in Oxygen [FiO2 0.3]).
Lead sponsor
Bayside Health
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2007
Completion date
September 30, 2013
Enrollment
7,112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.